Remove Chemotherapy Remove Compounding Remove Seminar
article thumbnail

FDA Approves Meloxicam Injection For Moderate-to-Severe Pain in Adults

Pharmacy Times

Seminars in Arthritis and Rheumatism. Azurity Pharmaceuticals announces the FDA approval of XIFYRM™ (meloxicam injection) for the management of moderate-to-severe pain in adults. PR Newswire. June 10, 2025. Accessed June 10, 2025. Meloxicam: Selective COX-2 inhibition in clinical practice. December 21, 2004.

FDA 73